Article (Scientific journals)
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Iseli, Thomas; Berghmans, Thierry; Glatzer, Markus et al.
2020In ERJ Open Research
Peer Reviewed verified by ORBi
 

Files


Full Text
Iseli et al., 2020.pdf
Publisher postprint (574.21 kB)
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
Non-small cell lung cancer; Surgery; Radiotherapy
Abstract :
[en] Background: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This study aims to analyse reporting of AEs in prospective stage III NSCLC trials, focussing on trials including radiotherapy and/or surgery. Methods: PubMed was searched for prospective studies dealing with stage III NSCLC from January 1987 to April 2019. Meta-analyses were screened as a positive control. Pearson’s Chi-squared test and smooth kernel distribution were used to estimate distributions. Data was resampled using bootstrapping. Results: Out of 1193 initially identified studies, 119 met the inclusion criteria. Of these, 31 had a surgical procedure in any study arm. Grade 3 and 4 AEs were reported in 94.12% and 92.44% of the included studies, respectively. Reporting of grade 5 AEs was provided in 87.39% of cases. Grade 1 and 2 AEs were less commonly reported at 53.78% and 63.03%, respectively. One study did not mention any AEs. Of the 31 treatment arms including any form of surgery, AEs were not reported in 10. Overall, 231 different AE items were reported, only 18 of them were included in at least 20% of the analysed studies. Conclusion: Overall, AE reporting in stage III NSCLC was inconsistent and inhomogeneous. Studies including surgical study arms often reported only treatment-related deaths in regards of surgical AEs. Underreporting of AEs prohibits the extraction of patient-relevant information for decision-making and represents a suboptimal use of invested resources.
Disciplines :
Surgery
Author, co-author :
Iseli, Thomas;  Kantonsspital St Gallen, St Gallen, Switzerland > Dept of Radiation Oncology
Berghmans, Thierry;  Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Glatzer, Markus;  Kantonsspital St Gallen, St Gallen, Switzerland > Dept of Radiation Oncology
Rittmeyer, Achim;  Lungenfachklinik Immenhausen, Immenhausen, Germany > Dept of Thoracic Oncology
Massard, Gilbert ;  University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Life Sciences and Medicine (DLSM)
Durieux, Valérie;  Université Libre de Bruxelles, Brussels, Belgium > Dept of Libraries and Information Science
Buchsbaum, Thomas;  Stadtspital Triemli, Zurich, Switzerland > Dept of Radiation Oncology
Putora, Paul Martin;  Kantonsspital St Gallen, St Gallen, Switzerland > Dept of Radiation Oncology
External co-authors :
yes
Language :
English
Title :
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Publication date :
14 September 2020
Journal title :
ERJ Open Research
ISSN :
2312-0541
Publisher :
European Respiratory Society, Sheffield, United Kingdom
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBilu :
since 22 January 2021

Statistics


Number of views
112 (2 by Unilu)
Number of downloads
33 (2 by Unilu)

Scopus citations®
 
1
Scopus citations®
without self-citations
0
OpenCitations
 
0
WoS citations
 
1

Bibliography


Similar publications



Contact ORBilu